Medical Devices: Page 68
-
Getty Images
Coloplast to pay $1.2B upfront to buy fish skin wound care business Kerecis
Kerecis’ fish skin biologic, which aids tissue regeneration, helped drive the company’s sales to $74.5 million last year.
By Nick Paul Taylor • July 10, 2023 -
Permission granted by Medtronic
Medtronic secures Medicare coverage for MiniMed 780G insulin pump
Medtronic has begun processing orders and will start shipping devices over the next few weeks.
By Nick Paul Taylor • July 10, 2023 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Permission granted by Penumbra
Q&AQ&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment
Penumbra has launched two devices that use computers to control suction of blood clots. That’s helped the company convert some surgeons from traditional methods of clot removal, like open surgery or drugs.
By Elise Reuter • July 7, 2023 -
Permission granted by Becton Dickinson
BD to shed 60 jobs as COVID demand, diabetes spinoff affect manufacturing plant
The cuts are the latest in a wave of workforce reductions by medtech companies including Abbott Laboratories, Cook Medical, Illumina and Thermo Fisher Scientific.
By Nick Paul Taylor • July 7, 2023 -
Sean Gallup / Staff via Getty Images
Illumina’s ‘inevitable’ split from Grail likely by mid-2024, analysts say
Canaccord Genuity analysts, commenting on a Financial Times article predicting a record EU fine against the DNA sequencer for closing its Grail acquisition, said it looks “almost certain” regulators will force a divestiture.
By Susan Kelly • July 6, 2023 -
Carol Highsmith. (2005). "The Apex Building" [Photo]. Retrieved from Wikimedia Commons.
FTC intervenes to correct Medtronic’s ‘erroneous assertions’ in antitrust case
The FTC filed an amicus brief because it said Medtronic made “wrong” arguments with “broad implications for antitrust enforcement.”
By Nick Paul Taylor • July 6, 2023 -
Adam Berry via Getty Images
European guidelines offer support for renal denervation in hypertension, boosting Medtronic, ReCor
Medtronic hailed the updated guidelines as a “turning point” for the use of renal denervation in treating high blood pressure.
By Nick Paul Taylor • July 6, 2023 -
Getty Images
Medtronic identifies cybersecurity vulnerability in cardiac data system
Cyber attackers could exploit the vulnerability if healthcare organizations have enabled its optional messaging service, the device maker said.
By Susan Kelly • July 5, 2023 -
Courtesy of Abbott
Abbott secures FDA approval for dual-chamber leadless pacemaker
With the new device, Abbott is ramping up competition with Medtronic in the leadless pacemaker market.
By Elise Reuter • July 5, 2023 -
Courtesy of U.S. Food and Drug Administration
Startup’s fast-acting wound treatment gel gets FDA nod for use in humans
Cresilon raised $25 million last year as part of a push to expand its wound-gel product for animals into human health.
By Nick Paul Taylor • July 5, 2023 -
Courtesy of Dexcom
Q&AQ&A: Dexcom’s Lawver shares strategy behind CGM for non-insulin users
The continuous glucose monitor in development for people with Type 2 diabetes who don’t take insulin could expand the CGM market to 25 million more people in the U.S., the company’s new chief commercial officer said.
By Elise Reuter • June 30, 2023 -
Mario Tama via Getty Images
Diabetes remains fastest-growing medtech market despite some risk from new drugs: analysts
The medicines could apply “short-lived pressures” to medtech companies by affecting the use of insulin, Mizuho analysts say.
By Nick Paul Taylor • June 30, 2023 -
Getty Images
EU MDR costs could cause device shortages for children, medical groups warn
The cost of certification under new medical device regulations in Europe is a barrier to manufacturers that make devices for small groups of patients, medical associations said.
By Elise Reuter • June 29, 2023 -
Retrieved from Istock.
FDA seeks feedback on technologies that can enable healthcare at home
The FDA is asking the medtech industry for input on how the agency can support development of devices for use in non-clinical care settings and by diverse patient populations.
By Nick Paul Taylor • June 29, 2023 -
Sarah Silbiger via Getty Images
FDA repeats restrictions on NuVasive limb-lengthening device after clearing pediatric use
The agency in March cleared NuVasive to market its Precice limb-lengthening system for use in the femur and tibia of children aged 12 years and up.
By Nick Paul Taylor • June 29, 2023 -
Mario Tama via Getty Images
Former J&J sales rep indicted on charges of defrauding Boston hospital
The former J&J employee is accused of bilking the hospital out of hundreds of thousands of dollars’ worth of spine products.
By Susan Kelly • June 28, 2023 -
Sarah Silbiger/Getty Images via Getty Images
Teleflex recall of separating vascular catheters labeled Class I event
The company began the recall in May after receiving 83 complaints, including 18 reports of injuries, related to the fault.
By Nick Paul Taylor • June 28, 2023 -
Getty Images
Invacare names Kai Zhu as CFO
The promotion positions Zhu to help lead the manufacturer of non-acute care medical equipment as it works to recover from a bankruptcy filing.
By Nick Paul Taylor • June 28, 2023 -
Proposed EtO limits garner criticism from device industry, praise from occupational health groups
Lobbyists representing medical device companies say the proposed policy would reduce capacity at commercial sterilizers by as much as 50%.
By Elise Reuter • June 27, 2023 -
Permission granted by Politan Capital Management
Masimo shareholders elect activist investor’s two board candidates
The vote approving Politan Capital’s nominees is “a clear mandate from shareholders that significant change is needed at Masimo,” said newly elected director Quentin Koffey.
By Susan Kelly • Updated June 27, 2023 -
Getty Images
Restor3d inks Conformis buyout, adding hip and knee implants to portfolio
Restor3d, which makes 3D-printed devices for spine, ankle and upper extremity procedures, is buying Conformis at a 96% premium.
By Nick Paul Taylor • June 27, 2023 -
Getty Images
More than 1 billion people could have diabetes by 2050, study says
A pair of studies published in the Lancet show that spending on diabetes care is expected to rise, but more work is needed to address structural inequities that affect access to treatment.
By Elise Reuter • June 26, 2023 -
Permission granted by Medtronic
Medtronic links 780G insulin pump to benefits in kids as it works to grow sales
A clinical trial found adolescent users of the pump can achieve improved blood glucose control without precisely counting carbohydrates.
By Nick Paul Taylor • June 26, 2023 -
Courtesy of Dexcom
Dexcom targets 25M Americans with new CGM aimed at non-insulin-using diabetics
The device will last for 15 days, include a cash-pay option and come with software designed for the needs of people who are yet to require insulin.
By Nick Paul Taylor • June 26, 2023 -
Courtesy of BusinessWire/Masimo
Deep DiveShowdown at Masimo: Proxy battle targets CEO Kiani’s leadership, board
Shareholders are voting on whether to add investor Politan Capital’s picks to the board of the pulse oximeter maker, a move that could change the company’s direction.
By Susan Kelly • June 23, 2023
Previous
